My Ultimate Sign-in System Made Me Invincible - Chapter 469 The Old Guards

Chapter 469  The Old Guards

The private dining room at the club had been reserved under a member name that appeared nowhere in public records, in a building whose ownership structure was deliberately opaque, for a meeting that would generate no minutes and leave no paper trail.

Twelve men sat around a table that had hosted similar conversations for more than a century. Old money. The kind of wealth that didn’t appear on Forbes lists because it had been carefully distributed across trusts, foundations, and corporate structures specifically designed to avoid that kind of visibility.

They represented banking dynasties, industrial fortunes, resource extraction empires, and investment vehicles that moved markets without announcing their presence. Some of their families had been influential when Standard Oil was broken up. Others had navigated the creation of the Federal Reserve. All of them understood that real power operated quietly, and that the most effective influence was the kind nobody noticed.

The youngest person at the table was sixty-three. The eldest had recently turned ninety-two and still attended every meeting with the kind of sharp focus that had built his family’s position over four generations.

They had convened within eighteen hours of the Medical Nanites announcement, canceling prior commitments across three continents to be physically present. Video conferences were for normal business. This required being in the same room.

The man who’d called the meeting spoke first. His family controlled significant positions in pharmaceutical distribution, medical device manufacturing, and healthcare finance. The nanites announcement had erased approximately $40 billion from assets his family had direct or indirect stakes in.

“We need to be very clear about what we’re looking at,” he said, his voice carrying the kind of careful enunciation that came from decades of choosing words precisely. “This is not a competitor entering our markets. This is the elimination of markets we’ve operated in for generations. The distinction matters.”

One of the investment managers leaned forward. “Our analysts have been modeling scenarios since the announcement dropped. Under even conservative adoption curves, we’re looking at the complete restructuring of healthcare economics within a decade. Pharmaceuticals, insurance, hospitals, medical devices—the entire value chain becomes obsolete or radically diminished.”

“And that’s just healthcare,” someone else added. “Lucid Studio threatens entertainment production at similar scale. We’re watching multiple trillion-dollar industries face existential disruption simultaneously.”

The banker whose family had helped establish the modern pharmaceutical patent system spoke carefully. “The question we need to answer is whether this is something we can influence, adapt to, or simply must accept. I’ve spent the past day reaching out to contacts in regulatory agencies, congressional offices, and international bodies. The consensus is troubling. No one has leverage. Regulatory authority doesn’t extend to off-world facilities. Economic pressure doesn’t work when they’re not seeking capital or partnerships. Political pressure fails when public opinion overwhelmingly supports the technology.”

“And that’s just healthcare,” someone else added. “Lucid Studio threatens entertainment production at similar scale. We’re watching multiple trillion-dollar industries face existential disruption simultaneously.”

The banker whose family had helped establish the modern pharmaceutical patent system spoke carefully. “The question we need to answer is whether this is something we can influence, adapt to, or simply must accept. I’ve spent the past day reaching out to contacts in regulatory agencies, congressional offices, and international bodies. The consensus is troubling. No one has leverage. Regulatory authority doesn’t extend to off-world facilities. Economic pressure doesn’t work when they’re not seeking capital or partnerships. Political pressure fails when public opinion overwhelmingly supports the technology.”

“What about the institutional banking partner?” someone asked. “Whitlock at JP Morgan. He has direct communication with them.”

“He’s been… uncooperative,” the banker said delicately. “Not hostile. But he’s made it clear that his relationship with Nova Technologies is not something he’s willing to risk for our benefit. He gave us the same courtesy warning he gave the government—advance notice that something was coming. Nothing more.”

The room absorbed that in silence.

The industrial magnate whose fortune had been built on resource extraction and manufacturing spoke next. His family had weathered technology disruptions before—the shift from coal to oil, the automation of factories, the rise of digital systems that replaced physical production. But this felt different.

“We’ve always adapted by acquiring new technologies, integrating them into our holdings, and maintaining position through control of essential infrastructure,” he said. “That model requires the technology to be acquirable. Nova Technologies isn’t selling. They’re not seeking investment. They’re not licensing their intellectual property. There’s nothing for us to acquire, nothing to integrate, no pathway to control.”

“Have we attempted acquisition offers?” someone asked.

“Of course. Immediately after the Lucid launch, we had intermediaries reach out with purchase proposals. Blank check offers. The responses were no responses. We’ve tried again since with similar results. They’re simply not interested in being acquired at any price.”

“What about their supply chain? Can we identify dependencies, create leverage through suppliers or manufacturers?”

“We’ve tried. Their supply chain is either completely opaque or doesn’t exist in conventional form. Our best intelligence suggests they’re manufacturing in locations we can’t identify using processes we don’t understand. The off-world facility reference in the Medical Nanites announcement supports that theory.”

One of the younger members—relatively speaking, at sixty-three—spoke up. “Perhaps we’re approaching this wrong. Instead of trying to control Nova Technologies, we should be positioning ourselves to benefit from the disruption they’re creating. Identify the adjacencies, the complementary services, the infrastructure plays that emerge from their technology deployment.”

The eldest member, who had been silent until now, made a small sound that might have been amusement. Everyone turned to look at him.

“That is the correct strategic response for a venture capitalist or an opportunistic investor,” he said, his voice thin but clear. “It is not the correct response for families whose position depends on controlling foundational systems. We don’t participate in markets. We structure them. That’s how generational wealth maintains itself across centuries. And what Nova Technologies is doing isn’t just disrupting markets. It’s restructuring the systems we’ve spent generations positioning ourselves within.”

He paused, and the room waited.

“The healthcare system as it currently exists was built deliberately. Not all at once, not by any single actor, but through accumulated decisions by people in positions much like ours. Patent law that protects pharmaceutical profits. Regulatory frameworks that create barriers to entry. Insurance structures that extract value from the inevitable. It’s not a conspiracy. It’s simply how power consolidates around scarce resources. We found ways to profit from scarcity—of medicines, of treatments, of access to care.”

“Nova Technologies eliminates the scarcity. And when scarcity disappears, the entire architecture of profit extraction built around managing it becomes irrelevant. That’s not something we can adapt to through portfolio rebalancing. That’s a change in the fundamental nature of the game.”

The room was completely silent now.

“So what do we do?” someone asked.

The eldest member considered this. “We do what we can only do when faced with forces we cannot control. We acknowledge reality. We protect what can be protected. We diversify away from assets that will be destroyed. And we position the next generation to thrive in whatever system emerges, rather than trying to preserve a system that’s already dying.”

“That’s acceptance,” the pharmaceutical heir said, his voice carrying an edge. “We’re just accepting this?”

“I’m suggesting we not waste time and resources fighting battles we’ve already lost. The Medical Nanites exist. The clinical trials will demonstrate their efficacy. Public pressure will force governments to allow deployment. Our choice is whether we spend our energy trying to delay the inevitable and make enemies of the very people who might be amenable to reasonable partnerships, or whether we adapt quickly and maintain relevance in the new order.”

“What about using our media holdings to shape public perception?” someone suggested. “If we can create doubt about the safety—”

“No.” The word came from the banker, sharp and final. “I’ve reviewed the same analysis you have. Any attempt to undermine Nova Technologies publicly will backfire spectacularly. They’re offering cures for cancer, Alzheimer’s, paralysis. If we position ourselves in opposition to that, we become villains in the most literal sense. The public will destroy us, and they’ll be right to do it.”

The private equity manager pulled up a document on his tablet. “I’ve had my team gaming out scenarios. The outcomes where we maintain the most wealth and influence are the ones where we cooperate with Nova Technologies’ deployment, offer complementary services, and transition our holdings toward assets that benefit from rather than compete with their technology. The outcomes where we lose everything are the ones where we fight them openly or attempt to sabotage their rollout.”

“So we just… let them win?”

“They’ve already won,” the eldest member said quietly. “They won the moment they demonstrated technology we cannot replicate, operating from infrastructure we cannot reach, with public support we cannot undermine. The question now is whether we survive the transition they’re forcing or whether we cling to the old system until it drags us down with it.”

Another long silence settled over the room.

The host of the meeting spoke again. “I propose we take a formal position. We do not oppose Nova Technologies publicly. We do not attempt to undermine their technology or deployment. We explore partnership opportunities where they exist. We transition our holdings away from directly threatened assets and toward positions that remain viable or benefit from the new landscape. And we prepare the next generation to operate in a world where our traditional sources of influence are significantly diminished.”

He looked around the table. “This is not the outcome I wanted. But it’s the reality we face. All in favor?”

Eleven hands went up. Some quickly, some with visible reluctance, but all eventually rose.

“Carried,” the host said.

The meeting continued for another hour, shifting from strategic positioning to practical logistics. Which assets to divest and on what timeline. Which partnerships to pursue. Which members of the next generation needed to be briefed on the changed landscape. How to maintain family wealth and influence in a world where Nova Technologies had fundamentally altered the relationship between capital, technology, and power.

But the essential decision had been made. They would not fight Nova Technologies. They would adapt to the reality the company had created, preserve what they could, and hope that cooperation would leave them with enough influence to remain relevant in whatever system emerged.

It was a bitter recognition for men whose families had spent generations accumulating the kind of power that usually bent reality to their will. But they were pragmatic enough to recognize when they’d encountered a force that couldn’t be bent, couldn’t be bought, and couldn’t be broken.

When the meeting finally adjourned, the members dispersed to private cars and aircraft, returning to homes and offices across the world. None of them discussed what had been said. That was the nature of these gatherings—they happened, decisions were made, and then everyone moved forward as though the meeting had never occurred.

But in private conversations with trusted advisors, the effects would ripple outward.

The old guard had made their choice. They would not oppose the future Nova Technologies was building. They would simply try to find a place in it that preserved some fraction of what their families had built over centuries.

It was adaptation born of necessity rather than enthusiasm. But it was adaptation nonetheless.

And in boardrooms and private clubs around the world, similar conversations were happening among similar groups of people, all reaching similar conclusions through parallel reasoning.

The era of their complete dominance was ending. The question now was how much they could preserve during the transition, and whether the power structures they’d built would survive in diminished form or disappear entirely.

Nobody had a confident answer to that question. But they all recognized that fighting Nova Technologies openly would guarantee the worst outcome.